A 60-year-old man presents to the emergency department with right calf pain, swelling, and difficulty bearing weight on his right leg. He has no chest pain, shortness of breath, or syncope. His medical history includes type 2 diabetes, hypertension, and end-stage renal disease on hemodialysis. He had a left hemicolectomy for recurrent diverticulitis four weeks ago. Duplex ultrasonography shows a non-compressible right femoral vein, suggesting deep vein thrombosis (DVT).

What is the most appropriate next step in managing this patient, including various anticoagulant treatments and other interventions?

Options

A) Aspirin

B) Inferior vena cava filter placement

C) Low molecular weight heparin only

D) Low molecular weight heparin followed by warfarin

E) Rivaroxaban

F) Unfractionated heparin only

G) Unfractionated heparin followed by warfarin

Answer:

D) Low Molecular Weight Heparin Followed by Warfarin

Here’s How It Works-

Surgery (Left hemicolectomy)
↓

Immobilization during postoperative period
↓

Venous stasis due to ↓ mobility
↓

Venous stasis due to ↓ mobility

Blood flow slows in the legs
↓

Hypercoagulability

(Surgery causes ↑ clotting factors and ↓ fibrinolysis)
↓

Endothelial injury

Trauma from surgery may damage the vessel walls
↓

Virchow’s Triad activated

Combination of venous stasis, hypercoagulability, and endothelial injury ↑ risk of clot formation
↓

Deep Vein Thrombosis (DVT) forms in the right femoral vein
↓

Obstruction of venous return

Blood pooling in the affected leg → swelling, edema, pain
↓

Classic DVT signs:

Calf swelling, pain with dorsiflexion (Homan’s sign)
↓

Non-compressible vein on duplex ultrasonography confirms DVT
↓

Management Considerations in ESRD

LMWH and Rivaroxaban are contraindicated due to renal clearance
↓

Preferred anticoagulation:

• Start with Unfractionated Heparin (UFH) (short half-life, easily monitored)

• Transition to Warfarin (safe in ESRD, long-term anticoagulation)

Why Other Options Are Wrong?

Aspirin (A)
Action: Primarily an antiplatelet agent

Why It’s Wrong:

• DVT is a thrombus formation in veins, driven primarily by fibrin and coagulation factors, not platelets.

Inferior Vena Cava (IVC) Filter (B)
Action: Physically blocks clots from reaching the lungs

Why It’s Wrong:

• IVC filters are used only if:

  • Anticoagulation is contraindicated (e.g., high risk of bleeding)

  • Patient has recurrent clots while on anticoagulation

Low Molecular Weight Heparin (LMWH) only (C)
Action: Inhibits factor Xa and prevents clot formation

Why It’s Wrong:

• LMWH is renally excreted and contraindicated in end-stage renal disease (ESRD) due to the risk of accumulation and bleeding.

Low Molecular Weight Heparin followed by Warfarin (D)
Action: Initial anticoagulation with LMWH, followed by long-term warfarin

Why It’s Wrong:

• LMWH is not safe in patients with severe renal impairment (like this patient).

• Although warfarin is safe for ESRD, the initial use of LMWH is problematic.

Rivaroxaban (E)
Action: Direct factor Xa inhibitor

Why It’s Wrong:

• Rivaroxaban is also renally excreted and contraindicated in patients with end-stage renal disease, posing a risk of accumulation and severe bleeding.

Unfractionated Heparin only (F)
Action: Inhibits both thrombin and factor Xa, preventing further clot formation

Why It’s Wrong:

• Unfractionated heparin (UFH) is appropriate for initial management because it’s not renally excreted and can be carefully monitored.

• However, long-term anticoagulation with only UFH is impractical due to the need for continuous infusion or frequent injections.

Flashcards

Stay Hungry, Stay Curious!

Your Brother in This Struggle

Dr. Shoaib